Laura Catenacci

Dr. Laura Catenacci

Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2018 in Cells
Verified
Journal Article
Open access
PDF file
Elia BariElia Bari
Elia Bari
SPSara Perteghella
Sara Perteghella
Dario Di SilvestreDario Di Silvestre
Dario Di Silvestre
MSMarzio Sorlini
Marzio Sorlini
Laura CatenacciLaura Catenacci
Laura Catenacci
Maria Luisa TorreMaria Luisa Torre
Maria Luisa Torre
In this paper, a pilot production process for mesenchymal stem/stromal freeze-dried secretome was performed in a validated good manufacturing practice (GMP)-compliant cell factory. Secretome was purified from culture supernatants by ultrafiltration, added to cryoprotectant, lyophilized and characterized. We obtained a freeze-dried, “ready-off-the-shelf” and free soluble powder containing extracellular vesicles and proteins. In the freeze-dried product, a not-aggregated population of extracellular vesicles was detected by nanoparticle tracking analysis; Fourier transform infrared spectra showed the simultaneous presence of protein and lipids, while differential scanning calorimetry demonstrated that lyophilization process successfully occurred. A proteomic characterization allowed the identification of proteins involved in immune response, response to stress, cytoskeleton and metabolism. Moreover, the product was not cytotoxic up to concentrations of 25 mg/mL (on human fibroblasts, chondrocytes and nucleus pulposus cells by MTT assay) and was blood compatible up to 150 mg/mL. Finally, at concentrations between 5 and 50 mg/mL, freeze-dried secretome showed to in vitro counteract the oxidative stress damage induced by H2O2 on nucleus pulposus cells by MTT assay.

26 November 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Laura CatenacciLaura Catenacci
Laura Catenacci
RRRachele Rossi
Rachele Rossi
FSFrancesca Sechi
Francesca Sechi
DBDaniela Buonocore
Daniela Buonocore
MILENA SORRENTIMILENA SORRENTI
MILENA SORRENTI
Maria Cristina BonferoniMaria Cristina Bonferoni
Maria Cristina Bonferoni
Lipid nanoparticles (LNPs) have shown promise as a delivery system for nucleic acid-based therapeutics, including DNA, siRNA, and mRNA vaccines. The immune system plays a critical role in the response to these nanocarriers, with innate immune cells initiating an early response and adaptive immune cells mediating a more specific reaction, sometimes leading to potential adverse effects. Recent studies have shown that the innate immune response to LNPs is mediated by Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), which recognize the lipid components of the nanoparticles. This recognition can trigger the activation of inflammatory pathways and the production of cytokines and chemokines, leading to potential adverse effects such as fever, inflammation, and pain at the injection site. On the other hand, the adaptive immune response to LNPs appears to be primarily directed against the protein encoded by the mRNA cargo, with little evidence of an ongoing adaptive immune response to the components of the LNP itself. Understanding the relationship between LNPs and the immune system is critical for the development of safe and effective nucleic acid-based delivery systems. In fact, targeting the immune system is essential to develop effective vaccines, as well as therapies against cancer or infections. There is a lack of research in the literature that has systematically studied the factors that influence the interaction between LNPs and the immune system and further research is needed to better elucidate the mechanisms underlying the immune response to LNPs. In this review, we discuss LNPs’ composition, physico-chemical properties, such as size, shape, and surface charge, and the protein corona formation which can affect the reactivity of the immune system, thus providing a guide for the research on new formulations that could gain a favorable efficacy/safety profile.

1 March 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SPSara Perteghella
Sara Perteghella
BCBarbara Crivelli
Barbara Crivelli
Laura CatenacciLaura Catenacci
Laura Catenacci
MILENA SORRENTIMILENA SORRENTI
MILENA SORRENTI
Giovanna BruniGiovanna Bruni
Giovanna Bruni
TCTheodora Chlapanidas
Theodora Chlapanidas

26 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Maria Cristina BonferoniMaria Cristina Bonferoni
Maria Cristina Bonferoni
Carla Marcella CaramellaCarla Marcella Caramella
Carla Marcella Caramella
Laura CatenacciLaura Catenacci
Laura Catenacci
Bice ContiBice Conti
Bice Conti
Dorati RossellaDorati Rossella
Dorati Rossella
Giuseppe TripodoGiuseppe Tripodo
Giuseppe Tripodo
Tissue repair and regeneration is an interdisciplinary field focusing on developing bioactive substitutes aimed at restoring pristine functions of damaged, diseased tissues. Biomaterials, intended as those materials compatible with living tissues after in vivo administration, play a pivotal role in this area and they have been successfully studied and developed for several years. Namely, the researches focus on improving bio-inert biomaterials that well integrate in living tissues with no or minimal tissue response, or bioactive materials that influence biological response, stimulating new tissue re-growth. This review aims to gather and introduce, in the context of Italian scientific community, cutting-edge advancements in biomaterial science applied to tissue repair and regeneration. After introducing tissue repair and regeneration, the review focuses on biodegradable and biocompatible biomaterials such as collagen, polysaccharides, silk proteins, polyesters and their derivatives, characterized by the most promising outputs in biomedical science. Attention is pointed out also to those biomaterials exerting peculiar activities, e.g., antibacterial. The regulatory frame applied to pre-clinical and early clinical studies is also outlined by distinguishing between Advanced Therapy Medicinal Products and Medical Devices.

30 July 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Giovanna RassuGiovanna Rassu
Giovanna Rassu
MILENA SORRENTIMILENA SORRENTI
MILENA SORRENTI
Laura CatenacciLaura Catenacci
Laura Catenacci
BPBarbara Pavan
Barbara Pavan
LUCA FERRAROLUCA FERRARO
LUCA FERRARO
ADAlessandro Dalpiaz
Alessandro Dalpiaz
Cyclodextrins (CDs) are oligosaccharides widely used in the pharmaceutical field. In this review, a detailed examination of the literature of the last two decades has been made to understand the role of CDs in nasal drug delivery systems. In nasal formulations, CDs are used as pharmaceutical excipients, as solubilizers and absorption promoters, and as active ingredients due to their several biological activities (antiviral, antiparasitic, anti-atherosclerotic, and neuroprotective). The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as well as for nose-to-brain transport of drugs. In vitro and in vivo models currently employed are suitable to analyze the effects of CDs in nasal formulations. Therefore, CDs are versatile pharmaceutical materials, and due to the continual synthesis of new CDs derivatives, the research on the new nasal applications is an interesting field evolving in the coming years, to which Italian research will still contribute.

23 August 2017 in Materials
Verified
Journal Article
Open access
PDF file
Elia BariElia Bari
Elia Bari
Carla Renata ArciolaCarla Renata Arciola
Carla Renata Arciola
Barbara ViganiBarbara Vigani
Barbara Vigani
BCBarbara Crivelli
Barbara Crivelli
PMPaola Moro
Paola Moro
Maria Luisa TorreMaria Luisa Torre
Maria Luisa Torre
Some natural compounds have recently been widely employed in wound healing applications due to their biological properties. One such compound is sericin, which is produced by Bombix mori, while active polyphenols, polysaccharides and proteins are synthetized by Chlorella vulgaris and Arthrospira platensis microalgae. Our hypothesis was that sericin, as an optimal bioactive polymeric carrier for microencapsulation process, could also improve the regenerative effect of the microalgae. A solvent-free extraction method and spray drying technique were combined to obtain five formulations, based on algal extracts (C. vulgaris and A. platensis, Chl and Art, respectively) or silk sericin (Ser) or their mixtures (Chl-Ser and Art-Ser). The spray drying was a suitable method to produce microspheres with similar dimensions, characterized by collapsed morphology with a rough surface. Art and Art-Ser showed higher antioxidant properties than other formulations. All microspheres resulted in cytocompatibility on fibroblasts until 1.25 mg/mL and promoted cell migration and the complete wound closure; this positive effect was further highlighted after treatment with Art and Art-Ser. To our surprize the combination of sericin to Art did not improve the microalgae extract efficacy, at least in our experimental conditions.